A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

Clinical trial NCT03276598 · COMPLETED

Trial details

NCT number: NCT03276598
Sponsor: Helsinki University Central Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Pharmacogenetics

Start date: 1999-11-25
Primary completion: 2004-04-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.